Search Drug Information, Interactions, Images, Dosage & Side Effects

Anthracycline treatment for cancer linked to increased risk of congestive heart failure 07 Feb 2023
The use of anthracyclines in the treatment of cancer appears to carry a twofold risk of congestive heart failure, according to a study.

Retinal artery occlusion predicts macrovascular complications in patients with diabetes

07 Feb 2023

Healthy lifestyle keeps memory decline at bay in older adults

07 Feb 2023

Early response to vedolizumab linked to week 52 remission in ulcerative colitis

07 Feb 2023

6 healthy lifestyles to avert dementia

07 Feb 2023

5-ASA use in paediatric CD common, deviates from recommended practices

07 Feb 2023

DAPT with cilostazol reduces stroke recurrence without raising bleeding risk

07 Feb 2023

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

06 Feb 2023

Radiation therapy may raise colorectal cancer risk among Hodgkin's lymphoma survivors

06 Feb 2023

Isolated anti-HBc positivity ups liver-related death risk

06 Feb 2023

Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals

06 Feb 2023

SARS-CoV-2 Variants: Everything you need to know 01 Feb 2023;
The COVID-19 pandemic continues to evolve with the emergence of new SARS-CoV-2 variants. The variants of concern have the potential to impact the transmissibility, virulence, and clinical presentation of the disease, affecting the epidemiology, public health measures, and diagnostic and therapeutic options. Mutations in the spike protein of the virus have increased its ability to infect humans and evade neutralization by natural or immunisation-induced antibodies. The highly mutated Omicron variant of SARS-CoV-2 has multiple sublineages with varying transmissibility and immune evasion potential. Pre-exposure prophylaxis plays a crucial role in protecting the immunocompromised populations against severe disease; however, the rapidly changing landscape of the variants poses a major challenge to the current and future effectiveness of pre-exposure prophylactic monoclonal antibodies.

Knee osteoarthritis management with ESCEO guidelines: The importance of a multimodal approach

01 Feb 2023

The role of oral antivirals in COVID-19 treatment: Who, when, and how?

Dr. Roger Paredes, Dr. Nicola Petrosillo, Dr. Petrick Periyasamy, 30 Jan 2023

Antimicrobial resistance: Next global, public health threat after COVID-19

Pank Jit Sin, 10 Jan 2023

Roxatin

Contents : Rosuvastatin Ca

Indications/Uses : Adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-C, Apo B, total-C: HDL-C ratio & triglycerides & for increasing HDL-C in hyper- & dyslipidemic conditions. Reduce total mortality & risk of major CV events in adults w/ increased risk of ASCVD based on presence of CV disease risk markers. Primary dysbetalipoproteinemia (type III hyperlipoproteinemia); primary hypercholesterolaemia [type IIa including heterozygous familial hypercholesterolaemia (HeFH) & severe non-familial hypercholesterolaemia]; combined (mixed) dyslipidemia (type IIb); HoFH. Adjunctive therapy to diet to slow progression of atherosclerosis in adults as part of treatment strategy to lower total-C & LDL-C to target levels. Adjunct to diet to reduce total-C, LDL-C & Apo B levels in adolescents at least 1 yr post-menarche, 10-17 yr w/ HeFH.

Cruzor

Contents : Irbesartan

Indications/Uses : Essential HTN. Diabetic nephropathy w/ elevated serum creatinine & proteinuria (>300 mg daily) in patients w/ type 2 diabetes & HTN.

Amnoz

Contents : Amlodipine

Indications/Uses : 1st-line treatment of HTN, myocardial ischemia whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature.